XORTX Therapeutics Inc 20-F for FY2024
XORTX Therapeutics Inc. (XRTX)
20-F
2025-05-12
For: 2024-12-31
View Original
Added on
April 05, 2026
About this 20-F
XORTX Therapeutics Inc filed this 20-F on May 12, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $3.31M
- compared with a net loss of $2.16M a year earlier
- Diluted EPS
- -$1.15
- compared with -$1.09 a year earlier